Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial-Reference-Cited by-同舟云学术

Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial

Published:2018-06 Issue:6 Volume:68 Page:1163-1171
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Guiu Boris,Jouve Jean-Louis,Schmitt Antonin^ORCID,Minello Anne,Bonnetain Franck,Cassinotto Christophe,Piron Lauranne,Cercueil Jean-Pierre,Loffroy Romaric,Latournerie Marianne,Wendremaire Maëva,Lepage Côme,Boulin Mathieu

Publisher

Elsevier BV

Subject

Hepatology

Reference42 articles.

1. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma;J Hepatol,2012

2. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies;Marelli;Cardiovasc Intervent Radiol,2007

3. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)

4. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study;Chang;Cancer,1994

5. Arterial embolisation or chemoembolisation vs. symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial;Llovet;Lancet,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review;Cureus;2023-10-07

2. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review;eClinicalMedicine;2023-10

3. Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study;Investigational New Drugs;2023-07-12

4. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma;Acta Biomaterialia;2023-02

5. Drugs for TACE of HCC;Transarterial Chemoembolization (TACE);2023